Pioglitazone Hydrochloride Patent Expiration
Pioglitazone Hydrochloride is Used for managing and improving glycemic control in patients with type 2 diabetes. It was first introduced by Takeda Pharmaceuticals Usa Inc
Pioglitazone Hydrochloride Patents
Given below is the list of patents protecting Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Actos | US6303640 | Pharmaceutical composition |
Aug 09, 2016
(Expired) | Takeda Pharms Usa |
Actos | US5965584 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6150383 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6150384 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6166042 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6166043 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6172090 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6211205 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6271243 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Actos | US6329404 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
Pioglitazone Hydrochloride's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List